These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 26098552

  • 1. Prevalence of Low Bone Mass and Osteoporosis in Long-Term Users of the Injectable Contraceptive Depot Medroxyprogesterone Acetate.
    Modesto W, Bahamondes MV, Bahamondes L.
    J Womens Health (Larchmt); 2015 Aug; 24(8):636-40. PubMed ID: 26098552
    [Abstract] [Full Text] [Related]

  • 2. A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate.
    Viola AS, Castro S, Bahamondes MV, Fernandes A, Viola CF, Bahamondes L.
    Contraception; 2011 Nov; 84(5):e31-7. PubMed ID: 22018135
    [Abstract] [Full Text] [Related]

  • 3. Bone density in women receiving depot medroxyprogesterone acetate for contraception.
    Cundy T, Evans M, Roberts H, Wattie D, Ames R, Reid IR.
    BMJ; 1991 Jul 06; 303(6793):13-6. PubMed ID: 1830502
    [Abstract] [Full Text] [Related]

  • 4. Bone mineral density in long-term depot medroxyprogesterone acetate acceptors.
    Taneepanichskul S, Intaraprasert S, Theppisai U, Chaturachinda K.
    Contraception; 1997 Jul 06; 56(1):1-3. PubMed ID: 9306024
    [Abstract] [Full Text] [Related]

  • 5. Forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.
    Sanches L, Marchi NM, Castro S, Juliato CT, Villarroel M, Bahamondes L.
    Contraception; 2008 Nov 06; 78(5):365-9. PubMed ID: 18929732
    [Abstract] [Full Text] [Related]

  • 6. The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women.
    Orr-Walker BJ, Evans MC, Ames RW, Clearwater JM, Cundy T, Reid IR.
    Clin Endocrinol (Oxf); 1998 Nov 06; 49(5):615-8. PubMed ID: 10197077
    [Abstract] [Full Text] [Related]

  • 7. Bone density in long term users of depot medroxyprogesterone acetate.
    Gbolade B, Ellis S, Murby B, Randall S, Kirkman R.
    Br J Obstet Gynaecol; 1998 Jul 06; 105(7):790-4. PubMed ID: 9692421
    [Abstract] [Full Text] [Related]

  • 8. A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate.
    Cundy T, Ames R, Horne A, Clearwater J, Roberts H, Gamble G, Reid IR.
    J Clin Endocrinol Metab; 2003 Jan 06; 88(1):78-81. PubMed ID: 12519833
    [Abstract] [Full Text] [Related]

  • 9. The effect of depot medroxyprogesterone acetate (DMPA) on bone mineral density (BMD) and evaluating changes in BMD after discontinuation of DMPA in Chinese women of reproductive age.
    Gai L, Zhang J, Zhang H, Gai P, Zhou L, Liu Y.
    Contraception; 2011 Mar 06; 83(3):218-22. PubMed ID: 21310282
    [Abstract] [Full Text] [Related]

  • 10. Body weight and body composition of depot medroxyprogesterone acetate users.
    Dal'Ava N, Bahamondes L, Bahamondes MV, Bottura BF, Monteiro I.
    Contraception; 2014 Aug 06; 90(2):182-7. PubMed ID: 24780631
    [Abstract] [Full Text] [Related]

  • 11. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate.
    Clark MK, Sowers MR, Nichols S, Levy B.
    Fertil Steril; 2004 Dec 06; 82(6):1580-6. PubMed ID: 15589863
    [Abstract] [Full Text] [Related]

  • 12. Effect of depot medroxyprogesterone acetate on bone mineral density in adolescent women.
    Zhang MH, Zhang W, Zhang AD, Yang Y, Gai L.
    Chin Med J (Engl); 2013 Nov 06; 126(21):4043-7. PubMed ID: 24229671
    [Abstract] [Full Text] [Related]

  • 13. Bone mineral density and depot medroxyprogesterone acetate.
    Albertazzi P, Bottazzi M, Steel SA.
    Contraception; 2006 Jun 06; 73(6):577-83. PubMed ID: 16730487
    [Abstract] [Full Text] [Related]

  • 14. Long-term assessment of forearm bone mineral density in postmenopausal former users of depot medroxyprogesterone acetate.
    Viola AS, Castro S, Marchi NM, Bahamondes MV, Viola CF, Bahamondes L.
    Contraception; 2011 Aug 06; 84(2):122-7. PubMed ID: 21757052
    [Abstract] [Full Text] [Related]

  • 15. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls.
    Cromer BA, Stager M, Bonny A, Lazebnik R, Rome E, Ziegler J, Debanne SM.
    J Adolesc Health; 2004 Dec 06; 35(6):434-41. PubMed ID: 15581522
    [Abstract] [Full Text] [Related]

  • 16. Effects of the long-term use of depot medroxyprogesterone acetate as hormonal contraceptive on bone mineral density and biochemical markers of bone remodeling.
    Shaarawy M, El-Mallah SY, Seoudi S, Hassan M, Mohsen IA.
    Contraception; 2006 Oct 06; 74(4):297-302. PubMed ID: 16982229
    [Abstract] [Full Text] [Related]

  • 17. Human vaginal histology in long-term users of the injectable contraceptive depot-medroxyprogesterone acetate.
    Bahamondes MV, Castro S, Marchi NM, Marcovici M, Andrade LA, Fernandes A, Bahamondes L.
    Contraception; 2014 Aug 06; 90(2):117-22. PubMed ID: 24613369
    [Abstract] [Full Text] [Related]

  • 18. Bone density among long-term users of medroxyprogesterone acetate as a contraceptive.
    Paiva LC, Pinto-Neto AM, Faundes A.
    Contraception; 1998 Dec 06; 58(6):351-5. PubMed ID: 10095971
    [Abstract] [Full Text] [Related]

  • 19. Decline in bone mineral density with stress fractures in a woman on depot medroxyprogesterone acetate. A case report.
    Harkins GJ, Davis GD, Dettori J, Hibbert ML, Hoyt RA.
    J Reprod Med; 1999 Mar 06; 44(3):309-12. PubMed ID: 10202754
    [Abstract] [Full Text] [Related]

  • 20. Long-term depot-medroxyprogesterone acetate and bone mineral density.
    Tang OS, Tang G, Yip P, Li B, Fan S.
    Contraception; 1999 Jan 06; 59(1):25-9. PubMed ID: 10342083
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.